Michael B. Chancellor - 15 Mar 2024 Form 4 Insider Report for LIPELLA PHARMACEUTICALS INC. (LIPO)

Role
Chief Medical Officer, Director, 10%+ Owner
Signature
/s/ Michael B. Chancellor
Issuer symbol
LIPO
Transactions as of
15 Mar 2024
Transactions value $
$0
Form type
4
Filing time
19 Mar 2024, 18:24:14 UTC
Previous filing
15 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIPO Stock Options Award $0 +80,000 $0.000000 80,000 15 Mar 2024 Common Stock 80,000 $0.7700 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.